tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL

Ocular Therapeutix (OCUL) Technical Analysis

1,333 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Ocular Therapeutix is a Sell.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 6.05, while Ocular Therapeutix’s (OCUL) share price is $6.17, making it a Buy.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 6.62, while Ocular Therapeutix’s (OCUL) share price is $6.17, making it a Sell.

Ocular Therapeutix (OCUL) Pivot Points

May 18, 2024, 05:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.46
5.70
5.98
6.22
6.50
6.74
7.02
Fibonacci
5.70
5.90
6.02
6.22
6.42
6.54
6.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

May 18, 2024, 05:04 AM
Period
Simple
Exponential
MA5
6.08Buy
6.11Buy
MA10
5.94Buy
5.97Buy
MA20
5.48Buy
6.05Buy
MA50
7.40Sell
6.62Sell
MA100
6.78Sell
6.45Sell
MA200
5.01Buy
5.56Buy
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 5.97, while Ocular Therapeutix’s (OCUL) share price is $6.17, making it a Buy.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 6.45, while Ocular Therapeutix’s (OCUL) share price is $6.17, making it a Sell.
Ocular Therapeutix’s (OCUL) stock price is $6.17 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 7.40, creating a Sell signal.
Ocular Therapeutix’s (OCUL) stock price is $6.17 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 6.78, creating a Sell signal.
Ocular Therapeutix’s (OCUL) stock price is $6.17 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 5.01, creating a Buy signal.

Ocular Therapeutix (OCUL) Technical Indicators

May 18, 2024, 05:04 AM
Name
Value
Implied Action
RSI (14)
49.07
Neutral
STOCH (9,6)
71.52
Neutral
STOCHRSI (14)
83.18
Sell
MACD (12,26)
-0.26
Sell
ADX (14)
21.90
Neutral
Williams %R
-21.68
Buy
CCI (14)
83.00
Neutral
ATR (14)
0.54
-
Ultimate Oscillator
51.88
Neutral
ROC
28.54
Buy
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 49.07, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 21.90, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is 83.00, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is 28.54, creating a Buy signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Buy.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 49.07, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is -0.26, which suggests OCUL is a Sell.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 6.08, which suggests OCUL is a Buy.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 5.48, which suggests OCUL is a Buy.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 7.40, which suggests OCUL is a Sell.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 5.01, which suggests OCUL is a Buy.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -21.68, which suggests OCUL is a Buy.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is 83.00, which suggests OCUL is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis